Header cover image

U.S. Drug Retail Industry Analysis

UpdatedAug 10, 2025
DataAggregated Company Financials
Companies12
  • 7D2.1%
  • 3M0.8%
  • 1Y10.8%
  • YTDn/a

The Drug Retail industry is up 2.1% in the last week, with Walgreens Boots Alliance up 2.6%. This means that the industry has gained 11% over the past year. As for the next few years, earnings are expected to grow by 83% per annum.

Industry Valuation and Performance

Has the U.S. Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 10 Aug 2025US$11.8bUS$158.0b-US$6,422,791,258.2473.8x-1.8x0.07x
Tue, 08 Jul 2025US$11.4bUS$158.1b-US$6,426,931,381.8334.7x-1.8x0.07x
Thu, 05 Jun 2025US$11.2bUS$155.4b-US$5,907,832,713.54n/a-1.9x0.07x
Sat, 03 May 2025US$11.1bUS$155.3b-US$5,913,791,131.99n/a-1.9x0.07x
Mon, 31 Mar 2025US$11.1bUS$153.8b-US$8,968,800,570.33n/a-1.2x0.07x
Wed, 26 Feb 2025US$10.7bUS$153.8b-US$8,983,712,127.33n/a-1.2x0.07x
Fri, 24 Jan 2025US$11.6bUS$153.8b-US$8,983,539,719.66n/a-1.3x0.08x
Sun, 22 Dec 2024US$9.7bUS$151.0b-US$8,784,148,978.82n/a-1.1x0.06x
Tue, 19 Nov 2024US$8.7bUS$151.0b-US$8,795,001,728.35n/a-1x0.06x
Thu, 17 Oct 2024US$10.2bUS$151.0b-US$8,683,667,524.0480.3x-1.2x0.07x
Sat, 14 Sep 2024US$7.7bUS$147.8b-US$5,892,495,958.97n/a-1.3x0.05x
Mon, 12 Aug 2024US$9.3bUS$147.8b-US$5,884,430,161.58n/a-1.6x0.06x
Wed, 10 Jul 2024US$9.5bUS$147.8b-US$5,905,444,835.51n/a-1.6x0.06x
Fri, 07 Jun 2024US$13.9bUS$146.9b-US$6,131,699,175.20n/a-2.3x0.09x
Sun, 05 May 2024US$15.5bUS$146.9b-US$6,142,350,372.3138.5x-2.5x0.1x
Tue, 02 Apr 2024US$18.9bUS$146.9b-US$6,124,994,480.4733.6x-3.1x0.1x
Thu, 29 Feb 2024US$18.8bUS$144.7bUS$499.5m32.7x37.7x0.1x
Sat, 27 Jan 2024US$20.1bUS$144.8bUS$444.9m36.8x45.3x0.1x
Mon, 25 Dec 2023US$22.9bUS$141.4b-US$3,209,348,662.0050.1x-7.1x0.2x
Wed, 22 Nov 2023US$18.6bUS$164.8b-US$4,844,590,344.0056x-3.8x0.1x
Fri, 20 Oct 2023US$18.4bUS$141.3b-US$3,218,021,923.00361.3x-5.7x0.1x
Sun, 17 Sep 2023US$19.7bUS$138.4b-US$3,448,694,294.00361.3x-5.7x0.1x
Tue, 15 Aug 2023US$25.5bUS$138.3b-US$3,454,212,971.00361.3x-7.4x0.2x
Thu, 13 Jul 2023US$26.6bUS$138.3b-US$3,448,939,417.00361.3x-7.7x0.2x
Sat, 10 Jun 2023US$27.5bUS$135.5b-US$3,271,735,243.00n/a-8.4x0.2x
Mon, 08 May 2023US$28.1bUS$135.5b-US$3,266,613,457.00n/a-8.6x0.2x
Wed, 05 Apr 2023US$31.2bUS$135.5b-US$3,266,711,964.00n/a-9.6x0.2x
Fri, 03 Mar 2023US$30.8bUS$134.2b-US$3,076,209,225.00n/a-10x0.2x
Sun, 29 Jan 2023US$32.4bUS$134.3b-US$3,077,362,247.00n/a-10.5x0.2x
Tue, 27 Dec 2022US$33.6bUS$134.7bUS$4.2b7.7x8x0.2x
Thu, 24 Nov 2022US$36.4bUS$134.7bUS$4.2b8.3x8.7x0.3x
Sat, 22 Oct 2022US$30.0bUS$134.7bUS$4.2b6.8x7.1x0.2x
Mon, 19 Sep 2022US$30.0bUS$136.5bUS$5.0b5.8x6x0.2x
Wed, 17 Aug 2022US$36.6bUS$136.6bUS$5.0b7.1x7.4x0.3x
Price to Earnings Ratio

7.4x


Total Market Cap: US$36.6bTotal Earnings: US$5.0bTotal Revenue: US$136.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Drug Retail Industry Price to Earnings3Y Average 0.8x202320242025
Current Industry PE
  • Investors are pessimistic on the American Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading close to its 3-year average PS ratio of 0.14x.
Past Earnings Growth
  • Total earnings for the Drug Retail industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 5.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Drug Retail compare with similar industries?

US Market2.39%
Consumer Staples2.94%
Food and Staples Retail4.00%
Drug Retail2.14%
Big Box Super Stores4.46%
Food Retail2.57%
Food Distributors-1.30%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
WBA Walgreens Boots AllianceUS$11.942.6%
+US$259.7m
11.8%PS0.07x
EMPG Empro GroupUS$6.6619.8%
+US$9.2m
n/aPE73.8x
MGRX MangoceuticalsUS$1.868.8%
+US$1.8m
-60.8%PS42.9x
RDGT RidgetechUS$1.2410.7%
+US$702.0k
-37.4%PS0.06x

Latest News